Humana Specialty Pharmacy Expands Access to New Cancer Treatment Options
February 08 2022 - 8:00AM
Business Wire
Humana Specialty Pharmacy has announced two significant
additions to its comprehensive, personalized and targeted oncology
therapies.
Patients can now receive the following drugs, delivered to their
front doors in a fast and meaningful way, while Humana Specialty
Pharmacy supports them along their journey:
- TAGRISSO® (osimertinib), a drug that helps certain patients
with epidermal growth factor receptor-mutated (EGFRm) non-small
cell lung cancer (NSCLC) manage their disease.
- LENVIMA® (lenvatinib), a drug that helps patients with
different forms of cancer, including certain types of thyroid,
liver and kidney cancers.
Patients who receive TAGRISSO and LENVIMA from Humana Specialty
Pharmacy also benefit from its Oncology Center of Excellence where
Humana Specialty Pharmacy patient advocates and specialty
pharmacists are available to provide invaluable treatment guidance,
including help with managing daily symptoms, assistance on how and
when to take medications, and any other questions they may have
with respect to staying on their therapy.
“We are honored to be able to dispense these therapies and offer
differentiated service and experience to patients through our
Oncology Center of Excellence,” said Natalie Bedford, SVP, Humana
Specialty Pharmacy. “At Humana Specialty Pharmacy, we are committed
to providing a holistic and personal health care experience for all
of the patients we serve, to drive overall better health
outcomes.”
Humana Specialty Pharmacy, a part of Humana Pharmacy, manages
therapies for chronic and complex illnesses while providing
patients with both clinical and educational services customized to
their individual needs and treatment goals.
More information about Humana Specialty Pharmacy can be found
here.
About Humana Humana Inc. (NYSE: HUM) is committed to
helping our millions of medical and specialty members achieve their
best health. Our successful history in care delivery and health
plan administration is helping us create a new kind of integrated
care with the power to improve health and well-being and lower
costs. Our efforts are leading to a better quality of life for
people with Medicare, families, individuals, military service
personnel, and communities at large.
To accomplish that, we support physicians and other health care
professionals as they work to deliver the right care in the right
place for their patients, our members. Our range of clinical
capabilities, resources and tools – such as in-home care,
behavioral health, pharmacy services, data analytics and wellness
solutions – combine to produce a simplified experience that makes
health care easier to navigate and more effective.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases and conference calls
- Calendar of events
- Corporate Governance information
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220208005470/en/
Lisa Dimond Humana Corporate Communications 832-330-4702
ldimond@humana.com
Humana (NYSE:HUM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2023 to Jul 2024